Researchers at the University of Munich have demonstrated a conceptually novel nanocarrier strategy in which the nanoparticles are both the cargo and the carrier.
A new AI system can identify optimal combinations of drugs and dosages in a matter of days to help halt viral pandemics before they reach global scales.
Remdesivir, an anti-viral agent known to be effective against MERS, is already in human trials as researchers search for a treatment for COVID-19.
3D mesh device prototype for ankle braces and other medical supports.
Moving away from our dependence on antibiotics through alternative antimicrobial strategies.
Artificial biomotors for in vivo therapeutic applications.
Arsenic trioxide is a promising novel latency-reversing agent to achieve the goal of eradicating HIV-1.
Brain organoids model normal human brain development and can be used to answer questions related to development, evolution, and disease.
Carbohydrates are abundant biomolecules with a strong tendency to form supramolecular networks.
Photodynamic therapy combines light and a photosensitizer to generate reactive oxygen species to induce cellular damage.
The Droplet Microarray (DMA) is a high-throughput platform for drug screening.
Novel biocompatible nanocapsules for combined nanocatalytic, photothermal, and chemotherapy.
Distinguishing tumors from normal brain cells is important in diagnosis and is particularly challenging in glioma (a type of tumor that occurs in the brain and spinal cord) surgery due to the lack of clear interfaces between healthy and affected cells. Prof. Marie...